Product correctly added to cart.

No image

CAS 896419-17-3: Olmesartan medoxomil impurity II

Description:Olmesartan medoxomil impurity II, with the CAS number 896419-17-3, is a chemical compound that serves as an impurity associated with the pharmaceutical agent olmesartan medoxomil, which is primarily used as an antihypertensive medication. This impurity is characterized by its specific molecular structure, which may differ slightly from the parent compound, potentially affecting its pharmacological properties. Typically, impurities like this one are monitored during the drug manufacturing process to ensure product quality and safety. The compound is likely to exhibit properties such as solubility in organic solvents and stability under standard laboratory conditions, although specific solubility and stability data would depend on the precise conditions and formulation. Regulatory guidelines often dictate the acceptable levels of such impurities in pharmaceutical products, emphasizing the importance of thorough characterization and analysis during drug development and quality control processes. Understanding the characteristics of impurities is crucial for ensuring the efficacy and safety of the final pharmaceutical product.

Sort by


See more categories

This search does not contain any category.

Found 4 products.

discount label

Olmesartan Medoxomil Methyl Ether

CAS:896419-17-3

Ref: IN-DA003W3A

Undefined sizeTo inquire
Estimated delivery in United States, on Tuesday 12 Aug 2025
discount label

Olmesartan Medoxomil Impurity 13

CAS:896419-17-3

Ref: 4Z-O-0813

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Wednesday 13 Aug 2025
discount label

Ref: ST-EA-CP-O7022

10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Tuesday 30 Sep 2025
discount label

Olmesartan medoxomil methyl ether

CAS:896419-17-3

Discontinued product
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".